TY - JOUR
T1 - Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
AU - GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators
AU - Rautalin, Ilari
AU - Volovici, Victor
AU - Stark, Benjamin A.
AU - Johnson, Catherine O.
AU - Kaprio, Jaakko
AU - Korja, Miikka
AU - Krishnamurthi, Rita V.
AU - Nair, Balakrishnan Sukumaran
AU - Ranta, Annemarei
AU - Rinkel, Gabriel J. E.
AU - Vergouwen, Mervyn D. I.
AU - Abate, Yohannes Habtegiorgis
AU - Abbastabar, Hedayat
AU - Abd-Allah, Foad
AU - Abdelkader, Atef
AU - Abdi, Parsa
AU - Abdollahi, Arash
AU - Abdullahi, Auwal
AU - Abiodun, Olugbenga Olusola
AU - Aboagye, Richard Gyan
AU - Abouzid, Mohamed
AU - Abtahi, Dariush
AU - Rumeileh, Samir Abu
AU - Abualhasan, Ahmed
AU - Abualruz, Hasan
AU - Abukhadijah, Hana J.
AU - Abu-Zaid, Ahmed
AU - Adamu, Lawan Hassan
AU - Addo, Isaac Yeboah
AU - Adedoyin, Rufus Adesoji
AU - Adegboye, Oyelola A.
AU - Adra, Saryia
AU - Adzigbli, Leticia Akua
AU - Agyemang-Duah, Williams
AU - Ahinkorah, Bright Opoku
AU - Ahmad, Aqeel
AU - Ahmad, Danish
AU - Ahmadzade, Amir Mahmoud
AU - Ahmed, Ali
AU - Ahmed, Haroon
AU - Ahmed, Syed Anees
AU - Aji, Budi
AU - Akkaif, Mohammed Ahmed
AU - Al-Ajlouni, Yazan
AU - Al-Aly, Ziyad
AU - Albashtawy, Mohammed
AU - Ali, Mohammed Usman
AU - Alif, Sheikh Mohammad
AU - Alimohamadi, Yousef
AU - Aljunid, Syed Mohamed
AU - Alomari, Mahmoud A.
AU - Alrawashdeh, Ahmad
AU - Alsabri, Mohammed A.
AU - Salman, Rustam Al Shahi
AU - Altaf, Awais
AU - Al-Tammemi, Alaa B.
AU - Alvis-Guzman, Nelson
AU - Alwafi, Hassan
AU - Al-Wardat, Mohammad
AU - Al-Worafi, Yaser Mohammed
AU - Aly, Hany
AU - Alyahya, Mohammad Sharif Ibrahim
AU - Alzoubi, Karem H.
AU - Amani, Reza
AU - Amin, Tarek Tawfik
AU - Amindarolzarbi, Alireza
AU - Amusa, Ganiyu Adeniyi
AU - Anderlini, Deanna
AU - Angappan, Dhanalakshmi
AU - Anil, Abhishek
AU - Anuoluwa, Boluwatife Stephen
AU - Anwar, Saleha
AU - Anyasodor, Anayochukwu Edward
AU - Apostol, Geminn Louis Carace
AU - Arabloo, Jalal
AU - Areda, Demelash
AU - Ärnlöv, Johan
AU - Artamonov, Anton A.
AU - Artanti, Kurnia Dwi
AU - Arumugam, Ashokan
AU - Aryan, Zahra
AU - Asghari-Jafarabadi, Mohammad
AU - Ashemo, Mubarek Yesse
AU - Ashraf, Tahira
AU - Athar, Mohammad
AU - Athari, Seyyed Shamsadin
AU - Aujayeb, Avinash
AU - Awotidebe, Adedapo Wasiu
AU - Azadnajafabad, Sina
AU - Aziz, Shahkaar
AU - Azzam, Ahmed Y.
AU - Babu, Giridhara Rathnaiah
AU - Bagheri, Nasser
AU - Taghanaki, Pegah Bahrami
AU - Bahramian, Saeed
AU - Bai, Ruhai
AU - Baig, Atif Amin
AU - Bako, Abdulaziz T.
AU - Baltatu, Ovidiu Constantin
AU - Bam, Kiran
AU - Banach, Maciej
AU - Bandyopadhyay, Soham
AU - Banik, Biswajit
AU - Bardhan, Mainak
AU - Barker-Collo, Suzanne Lyn
AU - Barnighausen, Till Winfried
AU - Barqawi, Hiba Jawdat
AU - Barua, Lingkan
AU - Bastan, Mohammad Mahdi
AU - Basu, Sanjay
AU - Bell, Shelly L.
AU - Bensenor, Isabela M.
AU - Berhie, Alemshet Yirga
AU - Beyene, Kebede A.
AU - Bhagavathula, Akshaya Srikanth
AU - Bhaskar, Sonu
AU - Bhat, Ajay Nagesh
AU - Bhat, Vivek
AU - Bhatti, Gurjit Kaur
AU - Bhatti, Jasvinder Singh
AU - Bijani, Ali
AU - Bikbov, Boris
AU - Birhan, Mekuriaw Mesfin
AU - Birhanu, Mulugeta M.
AU - Bitra, Veera R.
AU - Boloor, Archith
AU - Borhany, Hamed
AU - Breitner, Susanne
AU - Brenner, Hermann
AU - Bugiardini, Raffaele
AU - Bulamu, Norma B.
AU - Butt, Zahid A.
AU - Cabral, Lucas Scotta
AU - dos Santos, Florentino Luciano Caetano
AU - Calina, Daniela
AU - Camera, Luis Alberto
AU - Campos, Luciana Aparecida
AU - Campos-Nonato, Ismael
AU - Capodici, Angelo
AU - Carvalho, Felix
AU - Castaneda-Orjuela, Carlos A.
AU - Catapano, Alberico L.
AU - Cegolon, Luca
AU - Chadwick, Joshua
AU - Chakraborty, Chiranjib
AU - Chakraborty, Promit Ananyo
AU - Chakraborty, Sandip
AU - Chandika, Rama Mohan
AU - Chanie, Gashaw Sisay
AU - Chattu, Vijay Kumar
AU - Chaudhary, Anis Ahmad
AU - Chi, Gerald
AU - Chichagi, Fatemeh
AU - Ching, Patrick R.
AU - Chopra, Hitesh
AU - Choudhari, Sonali Gajanan
AU - Chowdhury, Enayet Karim
AU - Chu, Dinh-Toi
AU - Chung, Sheng-Chia
AU - Columbus, Alyssa
AU - Criqui, Michael H.
AU - da Silva, Alanna Gomes
AU - Ohadi, Mohammad Amin Dabbagh
AU - Dadras, Omid
AU - Dai, Xiaochen
AU - Dalal, Koustuv
AU - Dalli, Lachlan L.
AU - D'Amico, Emanuele
AU - Dashti, Mohsen
AU - Davletov, Kairat
AU - De la Cruz-Góngora, Vanessa
AU - Debopadhaya, Shayom
AU - Delgado-Enciso, Ivan
AU - Dervišević, Emina
AU - Devanbu, Vinoth Gnana Chellaiyan
AU - Dewan, Syed Masudur Rahman
AU - Dhane, Amol S.
AU - Dibas, Mahmoud
AU - Do, Thanh Chi
AU - Do, Thao Huynh Phuong
AU - Dohare, Sushil
AU - Doheim, Mohamed Fahmy
AU - Dokova, Klara Georgieva
AU - Dongarwar, Deepa
AU - D'Oria, Mario
AU - Doshi, Ojas Prakashbhai
AU - Doshi, Rajkumar Prakashbhai
AU - Dowou, Robert Kokou
AU - Dsouza, Haneil Larson
AU - Dutta, Siddhartha
AU - Dziedzic, Arkadiusz Marian
AU - E'mar, Abdel Rahman
AU - Edvardsson, David
AU - Efendi, Defi
AU - Efendi, Ferry
AU - El Nahas, Nevine
AU - Elgendy, Islam Y.
AU - Elhadi, Muhammed
AU - Eltaha, Chadi
AU - Eltahir, Mohd Elmagzoub
AU - Emeto, Theophilus I.
AU - Fabin, Natalia
AU - Fagbamigbe, Adeniyi Francis
AU - Fahim, Ayesha
AU - Fakhradiyev, Ildar Ravisovich
AU - Fares, Jawad
AU - Faris, Pawan Sirwan
AU - Fauk, Nelsensius Klau
AU - Fazylov, Timur
AU - Fekadu, Ginenus
AU - Ferreira, Nuno
AU - Fetensa, Getahun
AU - Fischer, Florian
AU - Foschi, Matteo
AU - Fridayani, Ni Kadek Yuni
AU - Gaipov, Abduzhappar
AU - Gajjar, Avi A.
AU - Gandhi, Aravind P.
AU - Ganesan, Balasankar
AU - Garg, Ravindra Kumar
AU - Gebregergis, Miglas Welay
AU - Gebrehiwot, Mesfin
AU - Gebremeskel, Teferi Gebru
AU - Getie, Molla
AU - Ghadimi, Delaram J.
AU - Ghadirian, Fataneh
AU - Ghahramani, Sulmaz
AU - Ghasemzadeh, Afsaneh
AU - Ghazy, Ramy Mohamed
AU - Gholamalizadeh, Maryam
AU - Ghozy, Sherief
AU - Gil, Artyom Urievich
AU - Gilani, Jaleed Ahmed
AU - Gnedovskaya, Elena V.
AU - Goleij, Pouya
AU - Goulart, Alessandra C.
AU - Goulart, Barbara Niegia Garcia
AU - Guan, Shi-Yang
AU - Gupta, Sapna
AU - Habibzadeh, Farrokh
AU - Hadei, Mostafa
AU - Hadi, Najah R.
AU - Hamidi, Samer
AU - Hanifi, Nasrin
AU - Hankey, Graeme J.
AU - Harlianto, Netanja I.
AU - Haro, Josep Maria
AU - Kandel, Himal
AU - Naik, Ganesh R.
AU - Shorofi, Seyed Afshin
PY - 2025/8
Y1 - 2025/8
N2 - IMPORTANCE Nontraumatic subarachnoid hemorrhage (SAH) represents the third most common stroke type with unique etiologies, risk factors, diagnostics, and treatments. Nevertheless, epidemiological studies often cluster SAH with other stroke types leaving its distinct burden estimates obscure. OBJECTIVE To estimate the worldwide burden of SAH. DESIGN, SETTING, AND PARTICIPANTS Based on the repeated cross-sectional Global Burden of Disease (GBD) 2021 study, the global burden of SAH in 1990 to 2021 was estimated. Moreover, the SAH burden was compared with other diseases, and its associations with 14 individual risk factors were investigated with available data in the GBD 2021 study. The GBD study included the burden estimates of nontraumatic SAH among all ages in 204 countries and territories between 1990 and 2021. EXPOSURES SAH and 14 modifiable risk factors. MAIN OUTCOMES AND MEASURES Absolute numbers and age-standardized rates with 95% uncertainty intervals (UIs) of SAH incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) as well as risk factor-specific population attributable fractions (PAFs). RESULTS In 2021, the global age-standardized SAH incidence was 8.3 (95% UI, 7.3-9.5), prevalence was 92.2 (95% UI, 84.1-100.6), mortality was 4.2 (95% UI, 3.7-4.8), and DALY rate was 125.2 (95% UI, 110.5-142.6) per 100 000 people. The highest burden estimates were found in Latin America, the Caribbean, Oceania, and high-income Asia Pacific. Although the absolute number of SAH cases increased, especially in regions with a low sociodemographic index, all age-standardized burden rates decreased between 1990 and 2021: the incidence by 28.8% (95% UI, 25.7%-31.6%), prevalence by 16.1% (95% UI, 14.8%-17.7%), mortality by 56.1% (95% UI, 40.7%-64.3%), and DALY rate by 54.6% (95% UI, 42.8%-61.9%). Of 300 diseases, SAH ranked as the 36th most common cause of death and 59th most common cause of DALY in the world. Of all worldwide SAH-related DALYs, 71.6% (95% UI, 63.8%-78.6%) were associated with the 14 modeled risk factors of which high systolic blood pressure (population attributable fraction [PAF] = 51.6%; 95% UI, 38.0%-62.6%) and smoking (PAF = 14.4%; 95% UI, 12.4%-16.5%) had the highest attribution. CONCLUSIONS AND RELEVANCE Although the global age-standardized burden rates of SAH more than halved over the last 3 decades, SAH remained one of the most common cardiovascular and neurological causes of death and disabilities in the world, with increasing absolute case numbers. These findings suggest evidence for the potential health benefits of proactive public health planning and resource allocation toward the prevention of SAH.
AB - IMPORTANCE Nontraumatic subarachnoid hemorrhage (SAH) represents the third most common stroke type with unique etiologies, risk factors, diagnostics, and treatments. Nevertheless, epidemiological studies often cluster SAH with other stroke types leaving its distinct burden estimates obscure. OBJECTIVE To estimate the worldwide burden of SAH. DESIGN, SETTING, AND PARTICIPANTS Based on the repeated cross-sectional Global Burden of Disease (GBD) 2021 study, the global burden of SAH in 1990 to 2021 was estimated. Moreover, the SAH burden was compared with other diseases, and its associations with 14 individual risk factors were investigated with available data in the GBD 2021 study. The GBD study included the burden estimates of nontraumatic SAH among all ages in 204 countries and territories between 1990 and 2021. EXPOSURES SAH and 14 modifiable risk factors. MAIN OUTCOMES AND MEASURES Absolute numbers and age-standardized rates with 95% uncertainty intervals (UIs) of SAH incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) as well as risk factor-specific population attributable fractions (PAFs). RESULTS In 2021, the global age-standardized SAH incidence was 8.3 (95% UI, 7.3-9.5), prevalence was 92.2 (95% UI, 84.1-100.6), mortality was 4.2 (95% UI, 3.7-4.8), and DALY rate was 125.2 (95% UI, 110.5-142.6) per 100 000 people. The highest burden estimates were found in Latin America, the Caribbean, Oceania, and high-income Asia Pacific. Although the absolute number of SAH cases increased, especially in regions with a low sociodemographic index, all age-standardized burden rates decreased between 1990 and 2021: the incidence by 28.8% (95% UI, 25.7%-31.6%), prevalence by 16.1% (95% UI, 14.8%-17.7%), mortality by 56.1% (95% UI, 40.7%-64.3%), and DALY rate by 54.6% (95% UI, 42.8%-61.9%). Of 300 diseases, SAH ranked as the 36th most common cause of death and 59th most common cause of DALY in the world. Of all worldwide SAH-related DALYs, 71.6% (95% UI, 63.8%-78.6%) were associated with the 14 modeled risk factors of which high systolic blood pressure (population attributable fraction [PAF] = 51.6%; 95% UI, 38.0%-62.6%) and smoking (PAF = 14.4%; 95% UI, 12.4%-16.5%) had the highest attribution. CONCLUSIONS AND RELEVANCE Although the global age-standardized burden rates of SAH more than halved over the last 3 decades, SAH remained one of the most common cardiovascular and neurological causes of death and disabilities in the world, with increasing absolute case numbers. These findings suggest evidence for the potential health benefits of proactive public health planning and resource allocation toward the prevention of SAH.
KW - Global Burden of Disease Study 2021
KW - nontraumatic subarachnoid hemorrhage (SAH)
KW - stroke
KW - global burden
UR - http://www.scopus.com/inward/record.url?scp=105006638300&partnerID=8YFLogxK
U2 - 10.1001/jamaneurol.2025.1522
DO - 10.1001/jamaneurol.2025.1522
M3 - Article
C2 - 40406922
AN - SCOPUS:105006638300
SN - 2168-6149
VL - 82
SP - 765
EP - 787
JO - JAMA Neurology
JF - JAMA Neurology
IS - 8
ER -